Browsing Technical documents and research evidence on COVID-19 by Title
Now showing items 905-924 of 1749
-
Is there evidence that BCG vaccination has non-specific protective effects for COVID 19 infections or is it an illusion created by lack of testing?
(2020-04-24)The goal of this paper is to showcase that the COVID-19 disease pattern is evolving and to study the relationship between mandatory BCG policy and caseload/million or death/per million. We analyze seven recent publications ... -
Isolation of infectious zika virus from saliva and prolonged viral RNA shedding in a traveller returning from the dominican republic to Italy, January 2016
(2016-06)A young woman in her 20s was admitted to the Infectious Disease Unit of Venice City Hospital in Italy because of persisting fever (38°C) associated with arthralgia, myalgia, and macular cutaneous rash, that had developed ... -
Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia
(1969)A strain of Zika virus (P6-740) was isolated from one of 58 pools of 1,277 Aedes aegypti mosquitoes collected in cities and towns of peninsular Malaya. The mosquitoes in the positive pool were collected from shop houses ... -
Isolation of Zika Virus from Febrile Patient, Indonesia
(2016-06)Arthropodborne viruses (arboviruses) cause substantial human disease worldwide and have a pronounced effect on public health throughout Asia. Zika virus, discovered in Uganda in 1947 (1), is a flavivirus related to the ... -
Isolation, identification and genomic characterization of the Asian lineage Zika virus imported to China
(2016-06)Zika virus (ZIKV) used to be an unknown mosquito-borne flavivirus, and maintained its limited sylvatic circulation in a few African and Asian countries (Enfissi et al., 2016). Based on available clinical data, the symptoms ... -
“It ain’t over … . till it’s over!” Risk‐mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID‐19 pandemic
(2020-06-08)The available COVID‐19 literature has focussed on specific disease manifestations, infection control, and delivery or prioritisation of services for specific patient groups in the setting of the acute COVID‐19 pandemic. ... -
The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice
(2020-03-27)Novel coronavirus 2019 is a single‐stranded, ribonucleic acid virus that has led to an international pandemic of coronavirus disease 2019. Clinical data from the Chinese outbreak have been reported, but experiences and ... -
Italian Society of Interventional Cardiology (GISE) position paper for Cath lab‐specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID‐19
(2020-03-29)COVID‐19 pandemic raised the issue to guarantee the proper level of care to patients with acute cardiovascular diseases and concomitant suspected or confirmed COVID‐19 and, in the meantime safety and protection of healthcare ... -
Kawasaki and COVID-19 disease in children: a systematic review
(2020-09-21)Objective: To present scientific evidence based on a systematic literature review (PRISMA) evaluating the association of Kawasaki Disease (DK) and COVID-19 in children. Methods: For the selection of studies, a combination ... -
Key Considerations for Integrating Gender Equality into Health Emergency and Disaster Response: COVID-19, 4 June 2020
(2020-06-04)This document highlights key considerations for integrating gender equality into health emergency and disaster response, particularly in the context of COVID-19. Due to existing gender-based inequalities, specific and ... -
Key Messages and Actions for COVID-19 Prevention and Control in Schools
(2020-03)Purpose: Today, children and young people are global citizens, powerful agents of change and the next generation of caregivers, scientists, and doctors. Any crisis presents the opportunity to help them learn, cultivate ... -
Laboratory biosafety guidance related to coronavirus disease 2019 (COVID-19) Interim guidance 12 February 2020
The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients that meet the case definition of the novel pathogen identified in Wuhan, China, ... -
Laboratory Guidelines for Detection and Diagnosis of the Novel Coronavirus (2019-nCoV) Infection, February 01, 2020
(2020-02-01)Coronaviruses are a group of highly diverse RNA virus in the Coronaviridae family that are divided in 4 genera: alpha, beta, gamma and delta that cause disease varying from mild to severe in human and animals. There are ... -
Laboratory Guidelines for the Detection and Diagnosis of COVID-19 Virus Infection, 8 July 2020
(2020-07-08)In January 2020, the etiologic agent responsible for a cluster of severe pneumonia cases in Wuhan, China, was identified as being a novel betacoronavirus, distinct from SARS-CoV and MERS-CoV. On 11 February 2020, the ... -
Laboratory infection with Zika virus after vaccination against yellow fever
(2014)One of the authors contracted a Zika virus infection during laboratory work. Subsequent studies revealed an immunological response of the anamnestic type due to preceding yellow fever vaccinations which rendered difficult ... -
Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories
(2020)Background & objectives: An outbreak of respiratory illness of unknown aetiology was reported from Hubei province of Wuhan, People's Republic of China, in December 2019. The outbreak was attributed to a novel coronavirus ... -
Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases, Interim guidance, 2 March 2020
Overview. The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a ...